• Maria Sharapova says she first took the drug 10 years ago
• Manufacturer says it is designed for chronic heart conditionsThe Latvian company that manufactures meldonium says the normal course of treatment for the drug is four to six weeks – not the 10 years that Maria Sharapova says she used the substance. Related: Maria Sharapova's PR machine limits damage but raises uncomfortable questions | Bryan Armen Graham Continue reading...
Source: theguardian.com